The Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.


The Cure Starts Now has funded $24,934,877 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 161 grants at over 100 hospitals in 29 countries.




Yale University - $100,000

Amount
$100,000.00
Date
November 2013

Pre-Clinical Development of Novel DIPG Radiosensitizers

Monash Institute of Medical Research - $99,620

Amount
$99,620.00
Date
November 2013

Targeted Therapy and Stem Cell Therapy for DIPG

Cincinnati Children's Hospital - $205,000

Amount
$205,000.00
Date
November 2013

Establishment of an International Diffuse Intrinsic Pontine Glioma (DIPG) Registry

Ann and Robert H. Lurie Children's Hospital of Chicago - $100,000

Amount
$100,000.00
Date
November 2013

Ex-vivo expanded natural killer (NK) cells to target DIPG tumor cells in pre-clinical studies

The Hospital of Sick Children - $100,000

Amount
$100,000.00
Date
November 2013

Investigating Mechanisms of Therapeutic Resistance in DIPG.

Dana-Farber Cancer Institute - $50,000

Amount
$50,000.00
Date
November 2013

Phase II Trial of Molecularly Determined Treatment of Children and Young Adults with Newly Diagnosed Diffuse Intrinsic Pontine Gliomas.

Texas Children's Cancer Center - $100,000

Amount
$100,000.00
Date
November 2013

Targeting DIPGs in vivo in Intra-brain Stem Xenograft Mouse Models through Combined Radiation and Oncolytic Viral Therapy.

Children's National Medical Center - $99,979

Amount
$99,979.00
Date
November 2013

Comparative Proteomic and RNA Sequencing of DIPGs

Sydney Children's Hospital - $100,000

Amount
$100,000.00
Date
January 2013

Research of treatments for Diffuse Intrinsic Pontine Glioma (DIPG)

Stanford University Medical Center - $35,589

Amount
$35,589.00
Date
October 2012

A Combinatorial Approach to Target Cellular Subpopulations in DIPG

Texas Children's Cancer Center - $100,000

Amount
$100,000.00
Date
October 2012

Preclinical Evaluation of Novel BMI-1 Inhibitors In Vivo in Intra-Brainstem Orthotopic Xenograft Mouse Models

St. Jude's Children's Research Hospital - $15,000

Amount
$15,000.00
Date
October 2012

Establishment and Characterization of Renewable Tissue Resources for DIPG Research

DIPG Registry - $219,000

Amount
$219,000.00
Date
January 2012

Establishment of an International DIPG Registry

Texas Children's Cancer Center - $100,000

Amount
$100,000.00
Date
November 2011

Eliminating Therapy-Resistant Diffuse Intrinsic Pontine Gliomas with Oncolytic Picorna Virus SVV-001

Duke University - $82,049

Amount
$82,049.00
Date
November 2011

Preclinical Evaluation of Systemic and Direct Delivery of a PDGFR-Alpha Antibody